Author(s):
Shilpa Kamra, Himani, Anurag Bhatnagar, Shagun Malik, Vidushi Sheokand
Email(s):
shilpakamra777@gmail.com. , himanigupta2903@gmail.com , anuragbhatnagar61@gmail.com , malikshagun90@gmail.com , vidushi.sheokand@sgtuniversity.org
DOI:
10.52711/0974-360X.2026.00476 
Address:
Shilpa Kamra1, Himani2, Anurag Bhatnagar3, Shagun Malik4, Vidushi Sheokand5
1Reader, Department of Periodontology, Faculty of Dental Sciences, SGT University, Gurugram.
2MDS Student, Department of Periodontology, Faculty of Dental Sciences, SGT University, Gurugram.
3Reader, Department of Periodontology, Faculty of Dental Sciences, SGT University, Gurugram.
4Reader, Department of Periodontology , Faculty of Dental Sciences, SGT University, Gurugram.
5Professor and Head, Department of Periodontology, Faculty of Dental Sciences, SGT University, Gurugram.
*Corresponding Author
Published In:
Volume - 19,
Issue - 7,
Year - 2026
ABSTRACT:
Background: Chronic periodontitis is a prevalent inflammatory condition that leads to the destruction of periodontal tissues. While scaling and root planing (SRP) remains the gold standard for mechanical debridement, the use of local drug delivery systems (LDDS) can enhance therapeutic outcomes. Boric acid, known for its antimicrobial, anti-inflammatory, and osteogenic properties, has gained attention as a potential adjunct in periodontal therapy. Aim: This randomized clinical trial aimed to compare the clinical efficacy of 0.75% boric acid chip (BoroChip) and chlorhexidine (CHX) chip as adjuncts to SRP in patients with chronic periodontitis. Materials and Methods: 20 systemically healthy subjects aged 30–60 years with generalized chronic periodontitis were selected. Each participant underwent both interventions: one quadrant was treated with SRP + BoroChip, and the other with SRP+CHX chip. Clinical parameters including probing pocket depth (PPD), clinical attachment loss (CAL), and bleeding index (BI) were evaluated at baseline, 3 weeks, and 6 weeks and the results were assessed. Results: Both BoroChip and CHX groups demonstrated significant improvements in all clinical parameters over the 6-week period. The BoroChip group showed a consistent reduction in PPD (from 4.55mm to 3.20mm), gain in CAL (from 2.65mm to 1.60mm), and a significant decrease in BI (from 73.12 to 20.62). Although CHX showed slightly higher CAL gain, the differences between the groups were statistically insignificant (p>0.05). Notably, the BoroChip group showed an earlier and more marked reduction in BI, indicating better inflammation control. Conclusion: Boric acid chip proved to be a safe, effective, and economical adjunct to SRP in managing chronic periodontitis, demonstrating clinical outcomes comparable to chlorhexidine with enhanced anti-inflammatory benefits.
Cite this article:
Shilpa Kamra, Himani, Anurag Bhatnagar, Shagun Malik, Vidushi Sheokand. Comparative Evaluation of Borochip and Chlorhexidine Chip as Adjuncts to Mechanical Therapy in Periodontitis: A Randomized Clinical Trial. Research Journal of Pharmacy and Technology. 2026;19(7):3351-6. doi: 10.52711/0974-360X.2026.00476
Cite(Electronic):
Shilpa Kamra, Himani, Anurag Bhatnagar, Shagun Malik, Vidushi Sheokand. Comparative Evaluation of Borochip and Chlorhexidine Chip as Adjuncts to Mechanical Therapy in Periodontitis: A Randomized Clinical Trial. Research Journal of Pharmacy and Technology. 2026;19(7):3351-6. doi: 10.52711/0974-360X.2026.00476 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-7-63
REFERENCES:
1. Soesilawati P, Ummah NI, Syahnia SJM, Arini NL, Oki AS. The role of Porphyromonas gingivalis in oral biofilm: pathophysiology in chronic periodontitis. Res J Pharm Technol. 2023; 16: 1754.
2. Loos BG, Van Dyke TE. The role of inflammation and genetics in periodontal disease. Periodontol 2000 2020; 83: 26-39.
3. Kumar SB. Occurrence of bacteremia in patients with chronic periodontitis. Res J Pharm Technol. 2015; 8: 1605-6.
4. Murthy KK, Varghese S. Effect of nonsurgical periodontal therapy on serum lipid profile: prospective study. Res J Pharm Technol. 2019; 12: 3664-8.
5. Mombelli A. Microbial colonization of the periodontal pocket and its significance for periodontal therapy. Periodontol 2000 2018; 76: 85-96.
6. Shetty ND, Kamath DG, Shetty NJ. Chitosan – a promising agent for site specific drug delivery in periodontics. Res J Pharm Technol. 2023; 16: 6105-9.
7. Adriaens PA, Adriaens LM. Effects of nonsurgical periodontal therapy on hard and soft tissues. Periodontol 2000 2004; 36: 121-45.
8. Shalehin N, Hosoya A, Takebe H, Hasan MR, Irie K. Boric acid inhibits alveolar bone loss in rat experimental periodontitis through diminished bone resorption and enhanced osteoblast formation. J Dent Sci 2020; 15: 437-44.
9. Luan Q, Desta T, Chehab L, Sanders VJ, Plattner J, Graves DT. Inhibition of experimental periodontitis by a topical boron-based antimicrobial. J Dent Res 2008; 87: 148-52.
10. Pizzorno L. Nothing Boring About Boron. Integr Med (Encinitas) 2015; 14: 35- 48.
11. Mamajiwala A, Sethi KS, Mahale SA, Raut CP, Karde PA, Kale AM. Comparative Evaluation of Boric Acid Gel versus Chlorhexidine Gel in the Treatment of Chronic Periodontitis: Randomized, Placebo-Controlled Clinical Study. Contemp Clin Dent 2019; 10: 457-64.
12. Sağlam M, Arslan U, Buket Bozkurt Ş, Hakki SS. Boric acid irrigation as an adjunct to mechanical periodontal therapy in patients with chronic periodontitis: a randomized clinical trial. J Periodontol 2013; 84: 1297-308.
13. Ganvir MN, Parwani SR, Chaudhary DS, Parwani R, Dadlani H, Vikey AK, et al. Comparative Evaluation of Azadirachta indica (Neem) Chip and Soft Tissue Diode Lasers as a Supplement to Phase I Periodontal Therapy in Localized Chronic Moderate Periodontitis: A Randomized Controlled Clinical Trial. Int J Dent 2022; 2022: 6109040.
14. John J, Emmadi P, Ambalavanan N, Verma E. Comparative evaluation of adjunctive use of locally delivered tetracycline fiber (Actisite) with scaling and root planning in the treatment of chronic periodontitis: a clinical study. Res J Pharm Technol 2013; 6: 90-5.
15. Penmetsa GS, Bhavana P, Arunbhupati P, Meghana K, Kausalya P, Venkatalakshmi M. Comparative evaluation of the clinical efficacy of 3% satranidazole and 1% ornidazole (Ornigreat™) gel through local drug delivery system in the treatment of chronic periodontitis. Res J Pharm Technol. 2020; 13: 3675-80.
16. Asha A, MLV Prabhuji, Rashmi P, Roja Y, Shaeesta Khaleelahmed Bhavikatti. Pocket reduction with High Concentrated oxygen oral gel: A Preliminary Case Report. Research Journal of Pharmacy and Technology. 2022; 15: 4367-1.
17. Sharma B, Soundrapandian C, Bhutia S. Formulation, characterization and in-vitro evaluation of prolonged local drug delivery of antimicrobial on bone tissue formation. Res J Pharm Technol. 2023; 16: 1147.
18. Bhatt P, Bhargava A, Kamath V, Khurana C, Mukherjee P, Chhabra M. Active Leptospermum honey as a local drug delivery agent in patients with chronic periodontitis: a clinico-biochemical study. Res J Pharm Technol. 2022; 15: 5449-54.
19. Larasati DM, Darjanki CM, Krismariono A, Aljunaid MA, Qaid HR, Alkadasi B. Host modulation therapy (HMT), an indispensable part of periodontitis treatment: case report. Res J Pharm Technol. 2025; 18: 3101-4.
20. Abdel-Fatah R, Elhusseiny G.A, Saleh W. Therapeutic potential of boric acid as a local drug delivery agent in periodontitis: a comprehensive systematic review and meta-analysis. BMC Oral Health 2025; 25: 88.
21. Parmar P, Gubbihal R, Raju R. Comparing the effectiveness of boric acid and chlorhexidine irrigation as an adjunct to mechanical periodontal therapy in chronic periodontitis patients – A randomized clinical trial. International Journal of Oral Health Sciences. 2022; 12: 58-64.
22. Balci Yuce H, Toker H, Goze F. The histopathological and morphometric investigation of the effects of systemically administered boric acid on alveolar bone loss in ligature-induced periodontitis in diabetic rats. Acta Odontol Scand 2014; 72: 729-36.
23. Singhal S, Pradeep AR, Kanoriya D, Garg S, Garg V. Boric acid gel as local drug delivery in the treatment of class II furcation defects in chronic periodontitis: a randomized, controlled clinical trial. J Investig Clin Dent 2018; 9: e12279.
24. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975; 25: 229-35.
25. Joshi D., Garg T., Goyal A.K., Rath G. Advanced drug delivery approaches against periodontitis. Drug Deliv 2016; 23: 363–77.
26. Esposito E, Cortesi R, Cervellati F, Menegatti E, Nastruzzi C. Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies. J. Microencapsul 1997; 14: 175–87.
27. Mittelstaedt R, Kretz A, Levine M, Handa VL, Ghanem KG, Sobel JD, et al. Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review. Sex Transm Dis 2021; 48: e241-7.